CORLINE BIOMEDICAL AB |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 10.1 SEK | +3.06% |
|
+0.50% | -32.21% |
| 30/04 | Corline Biomedical AB Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| 14/02 | Corline Biomedical AB Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Hours!
Take advantage of the offer
* See conditions on site
| Sales 2024 * | 3.6Cr 33.3L 28Cr | Sales 2025 * | 6Cr 55.51L 46Cr | Capitalization | 22Cr 2.01Cr 167.67Cr |
|---|---|---|---|---|---|
| Net income 2024 * | -1.1Cr -10.18L -8.5Cr | Net income 2025 * | 2Cr 18.5L 15Cr | EV / Sales 2024 * | 5.58 x |
| Net cash position 2024 * | 1.6Cr 14.8L 12Cr | Net cash position 2025 * | 3Cr 27.75L 23Cr | EV / Sales 2025 * | 3.12 x |
| P/E ratio 2024 * |
-20.2
x | P/E ratio 2025 * |
11.1
x | Employees | 13 |
| Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 45.17% |
More Fundamentals
* Assessed data
More news
| 1 day | +3.06% | ||
| 1 week | +0.50% | ||
| Current month | -4.27% | ||
| 1 month | -10.62% | ||
| 3 months | -27.86% | ||
| 6 months | -17.89% | ||
| Current year | -32.21% |
1 week
9.70
10.10
1 month
9.6411.55
Current year
9.6416.80
1 year
9.6419.30
3 years
7.6019.85
5 years
7.6026.60
10 years
6.4031.00
| Managers | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 58 | 01/08/01 | |
Gunnar Tufveson
CTO | Chief Tech/Sci/R&D Officer | - | 01/18/01 |
Fredrik Carlsson
CTO | Chief Tech/Sci/R&D Officer | - | 01/11/01 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Magnus Nilsson
BRD | Director/Board Member | 68 | 18/20/18 |
| Director/Board Member | - | 01/05/01 | |
| Chairman | 51 | 01/05/01 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 14/24/14 | 10.1 | +3.06% | 6,633 |
| 13/24/13 | 9.8 | -2.97% | 3,932 |
| 10/24/10 | 10.1 | +0.50% | 9,275 |
| 08/24/08 | 10.05 | 0.00% | 898 |
| 07/24/07 | 10.05 | -1.95% | 14,881 |
Delayed Quote Nasdaq Stockholm, May 14, 2024 at 06:54 pm IST
More quotes
Corline Biomedical AB is a Sweden-based biotechnology company. It develops, manufactures and markets heparin-based solutions to improve kidney transplantation, cell therapies and applications in regenerative medicine.
Sector
Pharmaceuticals
Calendar
15/05/2024
- Annual General Meeting
EPS Revisions
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -32.21% | 1.94Cr | |
| +9.85% | 7.25TCr | |
| +12.28% | 911.43Cr | |
| -12.85% | 507.42Cr | |
| +60.16% | 501.29Cr | |
| +1.60% | 384.98Cr | |
| -19.20% | 245.97Cr | |
| +18.65% | 244.06Cr | |
| +24.62% | 227.16Cr | |
| -27.46% | 226.26Cr |
- Stock Market
- Equities
- CLBIO Stock